Actuate Therapeutics inks $21.7 mln Series B
Fort Worth, Texas-based Actuate Therapeutics Inc, a clinical stage biopharmaceutical company, has raised $21.7 million in Series B financing. Kairos Ventures led the round with participation from DEFTA Partners, Tech Coast Angels and Bios Partners.
17 May 2019•1 min read
